MDMaria de Fátima Haueisen Sander Diniz

Maria de Fátima Haueisen Sander Diniz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria de Fátima Haueisen Sander Diniz has a total of 137 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Intersection of Gender-Race/Color and Glycemic Control in Diabetes in Nine Years of Follow-up of the ELSA-Brazil Cohort

    by Gisseila Andrea Ferreira Garcia, Luana Giatti, Lidiane V. Camelo, Maria de Fátima Sander, Rosane Harter Griep, Maria de Jesus Mendes da Fonseca, Maria Inês Schmidt, Sandhi Maria Barreto

    This study investigated how social categories defined by the intersection of gender-race/color influence the trajectory of glycemic control in adults with type 2 diabetes mellitus (T2DM). Guided by intersectionality and ecossocial theories, the study analyzed 1,009 individuals with T2DM who participated in three in-person study visits of the ELSA-Brazil cohort. Glycemic control at each visit was defined by glycated hemoglobin (HbA1C) < 7%. Four glycemic control trajectories were established (glycemic control at all visits; inadequate control at one visit; inadequate control at two visits; inadequate control at three visits). Six intersectional categories of gender-race/color were created (white woman, brown woman, black woman, white man, brown man, and black man). The associations between the intersectional categories and the glycemic control trajectory were estimated by multinomial logistic regression adjusted for sociodemographic, behavioral, health, and insulin use factors. The prevalence of adequate glycemic control decreased over visits in all intersectional categories and was lowest among Black women. Compared to white women, all intersectional categories except white men had higher odds of inadequate glycemic control at all three visits after adjusting for age, especially black men (OR: 3.04; 95% CI: 1.58–5.85), followed by black women (OR: 2.99; 95% CI: 1.65–5.43), brown women (OR: 2.47; 95% CI: 1.36–4.46), and brown men (OR: 2.47; 95% CI: 1.40–4.39). These results reveal persistent inequalities in glycemic control among the most socially vulnerable intersectional groups of gender and race, suggesting that the distinct life experiences of these groups affect the control of their disease.


  • Open Access

    Desempenho do “a body shape index” como discriminador de obesidade e obesidade sarcopênica - ELSA-Brasil

    by Jane Kellen Silva, Odaleia Barbosa de Aguiar, Maria de Fátima Haueisen Sander Diniz, José Ueleres Braga, Rosane Harter Griep, Maria de Jesus Mendes da Fonseca

    Resumo Objetivou-se determinar o desempenho diagnóstico do ABSI para obesidade e obesidade sarcopênica, comparados aos resultados da bioimpedância (BIA) e do IMC, por sexo e faixa etária. Trata-se de um estudo seccional com 12.793 participantes da segunda onda do ELSA-Brasil, que obteve medidas de percentual de gordura corporal utilizando BIA e antropometria, verificando-se a performance dos testes diagnósticos para comparar os índices. Os resultados mostraram que, para obesidade, em homens nas três faixas etárias, a sensibilidade foi abaixo de 49%. A especificidade variou de 73% a 93%, sendo maior na faixa etária de 65 a 79 anos. Esse padrão foi encontrado para as mulheres, sendo a sensibilidade inferior a 42%; a especificidade variou entre 85% e 92%, sendo maior nas idosas. Quanto à obesidade sarcopênica, a sensibilidade e a especificidade entre os homens nas três faixas etárias foram de 72% e 99%, respectivamente. Entre as mulheres, a sensibilidade foi de aproximadamente 95%, e a especificidade em torno de 70% em todas as faixas etárias. O ABSI, comparado à BIA, mostrou reduzida capacidade de discriminar obesidade, mas mostrou-se bom marcador de obesidade sarcopênica.


  • Open Access

    Comparing diabetes prediction based on metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease: the ELSA-Brasil study

    by Gabriela Wünsch Lopes, Scheine Leite Canhada, Rodrigo Citton Padilha dos Reis, Maria de Fátima Haueisen Sander Diniz, Alessandra Carvalho Goulart, Luciana Costa Faria, Rosane Harter Griep, Hugo Perazzo, Bruce Bartholow Duncan, Maria Inês Schmidt

    We aimed to compare nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) definitions concerning diabetes prediction in a large sample of Brazilian adults. As a secondary objective, we compared associations between NAFLD/MASLD and diabetes across self-declared race/skin color groups. The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) is a prospective cohort study of Brazilian civil servants (35-74 years) enrolled from 2008 to 2010 and followed up from 2012-2014 and 2017-2019. We ascertained type 2 diabetes mellitus at baseline as well as follow-up visits based on self-reported diagnosis, medication use, and glycemic tests (fasting and 2h post-OGTT glucose and HbA1c). We excluded individuals with heavy alcohol consumption or self-reported cirrhosis/hepatitis. We analyzed 7,073 subjects. NAFLD was defined by ultrasound-based steatosis. Participants with steatosis and at least one cardiometabolic factor were considered as having MASLD. Cox proportional hazards models were performed to evaluate the association between NAFLD/MASLD and the incidence of type 2 diabetes mellitus. At baseline, 33.9% of individuals presented NAFLD and 32.5% presented MASLD. Over 9.4 years of follow-up, the relative increase in the incidence of diabetes was 78% for NAFLD (HR = 1.78; 95%CI: 1.58-2.01) and 88% for MASLD (HR = 1.88; 95%CI: 1.67-2.12). Associations did not differ significantly among race/skin color groups (p for interaction = 0.10 for MASLD and 0.08 for NAFLD). In this large cohort of middle-aged and older Brazilian adults, the relative incidence of diabetes was similar for NAFLD and MASLD definitions, with similar associations in all ethnic groups.


  • Open Access

    Dynapenia and sarcopenia: association with the diagnosis, duration and complication of type 2 diabetes mellitus in ELSA-Brasil

    by Débora Noara Duarte dos Santos, Carolina Gomes Coelho, Maria de Fátima Haueisen Sander Diniz, Bruce Bartholow Duncan, Maria Inês Schmidt, Isabela Judith Martins Bensenor, Claudia Szlejf, Rosa Weiss Telles, Sandhi Maria Barreto

    Sarcopenia (the loss of muscle mass, strength and skeletal muscle function) increases mortality and the risk of hospitalization in the older population. Although it is known that older adults with type 2 diabetes mellitus (T2DM) have a higher risk of dynapenia and sarcopenia, few studies have investigated these conditions in middle-aged populations. The objective of this study was to investigate whether T2DM, its duration, the presence of albuminuria, and glycemic control are associated with sarcopenia and its components in adults. The cross-sectional analysis was based on data from visit 2 of the Brazilian Longitudinal Study of Adult Health (2012-2014). The 2018 European Working Group on Sarcopenia in Older People criteria were used to define dynapenia, low appendicular muscle mass (LAMM), and sarcopenia (absent/probable/confirmed). The explanatory variables were: T2DM; duration of T2DM; T2DM according to the presence of albuminuria; and glycemic control (HbA1C < 7%) among people with T2DM. A total of 12,132 participants (mean age = 55.5, SD: 8.9 years) were included. The odds ratio for LAMM was greater among those with T2DM, T2DM duration from 5 to 10 years, and T2DM without albuminuria. Chances of dynapenia were higher among those with T2DM, T2DM duration > 10 years, and T2DM with and without albuminuria. The variables T2DM, T2DM ≥ 10 years, and T2DM with albuminuria increased the odds of probable sarcopenia, and T2DM duration from 5 to 10 years increased the odds of confirmed sarcopenia. The results support the importance of frequently monitoring the musculoskeletal mass and strength of individuals with T2DM to prevent sarcopenia and related outcomes.


  • Open Access

    Untangle the relationship of muscle mass and bone mineral content on handgrip strength: Results of ELSA-Brasil

    by Nayranne Hivina Carvalho Tavares, Brena Custodio Rodrigues, Soraia P. M. Arruda, Claudia Szlejf, Claudia Kimie Suemoto, Rosane Harter Griep, Maria de F. H. S. Diniz, Luana Giatti, Sandhi M. Barreto, Larissa Fortunato Araújo

    The study aims to investigate the independent association of muscle mass (MM) and bone mineral content (BMC) in the performance of the handgrip strength (HGS) test and whether there is effect modification by sex and age. In 12,491 participants from the ELSA-Brasil we estimated the associations between MM, BMC and HGS using linear regression models. All the analyses were performed for total population, also stratified for sex and age. For total population an interaction term was included between each explanatory variable of interest with sex and age to verify the presence of effect modification. We observed that the higher quintiles of MM and BMC were associated to an increasing in the mean of HGS compared to the first quintile, with greater magnitudes in men compared to women, also adults compared to elderly. When we estimated the independent effect of each exposure of interest, MM showed stronger effect in HGS in women, men and adults then BMC. In conclusion, we observed that higher amounts of MM and BMC are associated with higher HGS, regardless of sociodemographic characteristics, health conditions and lifestyle, with this effect being greater in men and adults.


  • Uncovering the Relationship Between Statins and Muscle Problems in the ELSA-Brasil MSK Cohort

    by Aline Fernandes Pedroso, Sandhi Maria Barreto, Rosa Weiss Telles, Luciana A. C. Machado, Maria de Fátima Haueisen Sander Diniz, Bruce Bartholow Duncan, Roberta Carvalho Figueiredo

    Purpose To investigate the association between statins and muscle problems in a highly diverse sample of Brazilian civil servants. Methods We conducted a cross-sectional data analysis at baseline of the ELSA-Brasil MSK cohort. Pain was identified through self-reported symptoms in large muscle groups (lower back and/or hips/thighs). Muscle strength was assessed using the five-times-sit-to-stand (FTSTS) and handgrip tests, with weakness defined as the lowest and highest quintiles of age- and sex-stratified handgrip strength and FTSTS performance time, respectively. Multivariable logistic regression analyses were conducted to investigate the association between statin use and muscle pain and weakness. Secondary analyses explored the impact of different types of statins and their duration of use on the response variables. Results A total of 2156 participants (mean age 55.6 ± SD 8.9, 52.8% women) were included, of whom 21.1% were taking statins and 25.1% reported muscle pain. We found no significant association between statin use and muscle problems. Secondary analysis on different types of statins revealed an association between atorvastatin and muscle weakness, as measured by the five-times-sit-to-stand test (OR 1.94, 95% CI 1.12–3.37), but not by the handgrip test (OR 0.75, 95% CI 0.29–1.42). No evidence was found to support a link between the duration of statin treatment and muscle problems. Conclusions This study challenges previous claims of an efficacy-effectiveness gap between experimental and observational literature on statins. The findings indicate that statin use does not contribute to muscular problems.


  • Open Access

    Body shape trajectories are associated with birth weight, current body mass index and sociodemographic conditions in participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): a multiple correspondence analysis

    by Isiyara Pimenta, Maria de Jesus da Fonseca, Rosane Griep, Sheila Matos, Maria de Fatima Diniz, Arlinda Moreno

    Depending on body shape trajectory, individuals may be more prone to develop chronic diseases in adulthood or older age, so the identification of factors associated with this is essential for encouraging the development of preventive public health strategies. This study was conducted among 14,014...

  • Open Access

    Liver steatosis as a predictor of incident diabetes in adults: a prospective evaluation in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

    by Luciana Costa Faria, Maria de Fátima Haueisen Sander Diniz, Luana Giatti, Maria Inês Schmidt, Alessandra Carvalho Goulart, Bruce Bartholow Duncan, Sandhi Maria Barreto

    Increasing epidemiological evidence suggests a bidirectional relationship between non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes, and that NAFLD may precede and/or promote the development of diabetes. This study aimed to investigate whether liver steatosis is associated with the incidence of diabetes in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). The ELSA-Brasil is an occupational cohort study of active or retired civil servants, aged 35-74 years, in six capital cities in Brazil. We excluded participants with diabetes at baseline, those who reported excessive alcohol consumption or with missing information on relevant covariates, and those with self-referred hepatitis or cirrhosis. In total, 8,166 individuals participated, and the mean duration of follow-up was 3.8 years. The Cox proportional regression model was used to estimate the adjusted hazard ratio (HR) for the associations. Abdominal ultrasonography was used to detect liver steatosis. In the follow-up period, the cumulative incidence of diabetes was 5.25% in the whole sample, 7.83% and 3.88% in the groups with and without hepatic steatosis, respectively (p < 0.001). Compared to those without steatosis, individuals with hepatic steatosis had an increased risk of developing diabetes (HR = 1.31; 95%CI: 1.09-1.56) after adjustment for potential confounders, including body mass index (BMI). Hepatic steatosis was an independent predictor of incident diabetes in the ELSA-Brasil cohort study. Physicians should encourage changes in lifestyle and screen for diabetes in patients with fatty liver.


  • Serum uric acid is a predictive biomarker of incident metabolic syndrome at the Brazilian longitudinal study of adult Health (ELSA – Brasil)

    by Maria de Fátima Haueisen Sander Diniz, Alline M.R. Beleigoli, Aline Isabel Rodrigues Galvão, Rosa Weiss Telles, Maria Inês Schmidt, Bruce B. Duncan, Isabela M. Benseñor, Antônio Luiz P. Ribeiro, Pedro G. Vidigal, Sandhi Maria Barreto


  • Open Access

    Association between neck circumference and non-alcoholic fatty liver disease: cross-sectional analysis from ELSA-Brasil

    by Laura Luiza Menezes Santos, Maria de Fátima Haueisen Sander Diniz, Alessandra Carvalho Goulart, Sandhi Maria Barreto, Roberta Carvalho Figueiredo

    Non-alcoholic fatty liver disease (NAFLD) has become a public health problem worldwide. Neck circumference (NC) is a simple anthropometric adiposity parameter that has been correlated with cardiometabolic disorders like NAFLD. To investigate the association between NC and NAFLD, considering their obesity-modifying effect, among participants from the Longitudinal Study of Adult Health (ELSA-Brasil) baseline study. Cross-sectional study at the ELSA-Brasil centers of six public research institutions. This analysis was conducted on 5,187 women and 4,270 men of mean age 51.8 (± 9.2) years. Anthropometric indexes (NC, waist circumference [WC] and body mass index [BMI]), biochemical and clinical parameters (diabetes, hypertension and dyslipidemia) and hepatic ultrasound were measured. The association between NC and NAFLD was estimated using multinomial logistic regression, considering potential confounding effects (age, WC, diabetes, hypertension and dyslipidemia). Effect modification was investigated by including the interaction term NC x BMI in the final model. The frequency of NAFLD and mean value of NC were 33.6% and 33.9 (± 2.5) cm in women, and 45.8% and 39.4 (± 2.8) cm in men, respectively. Even after all adjustments, larger NC was associated with a greater chance of moderate/severe NAFLD (1.16; 95% confidence interval [CI] for women; 1.05, 95% CI for men; P < 0.001). Presence of multiplicative interaction between NC and BMI (P < 0.001) was also observed. NC was positively associated with NAFLD in both sexes, regardless of traditional adiposity indexes such as BMI and WC. The magnitude of the association was more pronounced among women.